Valuation: Agilent Technologies, Inc.

Market Cap 42.16B 36.55B 34.26B 31.24B 58.78B 4,024B 59.72B 403B 157B 2,014B 158B 155B 6,720B P/E 2026 *
29x
P/E 2027 * 25.4x
Enterprise Value 43.16B 37.41B 35.07B 31.97B 60.16B 4,119B 61.13B 413B 161B 2,062B 162B 159B 6,878B EV / Sales 2026 *
5.79x
EV / Sales 2027 * 5.28x
Free-Float
99.81%
Yield 2026 *
0.69%
Yield 2027 * 0.74%
08-12 Morgan Stanley Adjusts Agilent Technologies PT to $175 From $160, Maintains Overweight Rating MT
07-23 Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers MT
07-21 Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift RE
07-20 HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited CI
07-14 Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma CI
07-14 Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers MT
07-13 Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating MT
07-08 Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis CI
07-06 Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 MT
07-01 Agilent Technologies Launches Xcelligence RTCA Esight AI Module CI
06-26 Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron… Zonebourse
06-25 Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 CI
06-25 Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. CI
1 day+0.71%
1 week+5.62%
Current month+7.89%
1 month+11.38%
3 months+32.42%
6 months+18.66%
Current year+9.72%
1 week 145.45
Extreme 145.45
150.24
1 month 125
Extreme 125
150.24
Current year 108.35
Extreme 108.35
150.24
1 year 108.35
Extreme 108.35
160.27
3 years 96.43
Extreme 96.43
160.27
5 years 96.43
Extreme 96.43
179.57
10 years 42.92
Extreme 42.92
179.57
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-20
Director of Finance/CFO 49 2025-11-16
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Chairman 75 2017-03-15
Director/Board Member 78 2010-12-31
Director/Board Member 72 2015-06-30
Date Insider Type Main position Quantity % Market Cap.
2/27/26 Tax

Chief Executive Officer

279 0.0001%
2/27/26 Tax

Executive/Senior Manager

89 0.0000%
2/27/26 Tax

Executive/Senior Manager

124 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.71%+5.62%+24.11%+17.68% 41.87B
-1.18%+2.74%+22.92%+9.58% 223B
-0.92%+1.96%-2.51%-20.17% 145B
0.00%+7.37%-16.81%+31.78% 142B
+0.53%+4.85%-49.57%+1.29% 74.52B
-0.53%+3.63%+19.16%+16.56% 53.63B
+0.03%-0.15%-16.01%-17.27% 50.14B
-0.63%+3.46%+39.31%+41.78% 40.89B
+2.09%+4.95%-2.04%+3.07% 32.65B
+0.33%+1.57%-21.35%+26.34% 32.6B
Average +0.24%+3.70%-0.28%+11.06% 83.57B
Weighted average by Cap. -0.18%+3.74%+0.90%+8.68%

Financials

2026 *2027 *
Net sales 7.45B 6.46B 6.05B 5.52B 10.38B 711B 10.55B 71.26B 27.82B 356B 27.96B 27.36B 1,187B 7.9B 6.85B 6.42B 5.85B 11.01B 754B 11.19B 75.58B 29.51B 377B 29.66B 29.01B 1,259B
Net income 1.47B 1.27B 1.19B 1.09B 2.04B 140B 2.08B 14.02B 5.47B 70.02B 5.5B 5.38B 234B 1.63B 1.42B 1.33B 1.21B 2.28B 156B 2.32B 15.64B 6.11B 78.09B 6.14B 6B 261B
Net Debt 992M 860M 806M 735M 1.38B 94.64B 1.4B 9.49B 3.7B 47.38B 3.72B 3.64B 158B -486M -421M -395M -360M -677M -46.36B -688M -4.65B -1.81B -23.21B -1.82B -1.78B -77.41B
Logo Agilent Technologies, Inc.
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (71.2%) and services (28.8%). Net sales are distributed geographically as follows: the United States (33.7%), China and Hong Kong (17.6%) and other (48.7%).
Employees
18,000
Date Price Change Volume
26-08-13 US$149.29 +0.71% 1,026,748
26-08-12 US$148.24 -0.84% 1,367,506
26-08-11 US$149.49 +0.52% 1,199,335
26-08-10 US$148.72 +1.88% 1,751,943
26-08-07 US$145.97 +3.28% 1,525,223
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
149.29USD
Average target price
160.11USD
Spread / Average Target
+7.24%

Quarterly revenue - Rate of surprise